Nancy E. Davidson is the director of the University of Pittsburgh Cancer Institute, associate vice chancellor for cancer research and Hillman Professor of Medicine at the University of Pittsburgh. She holds secondary appointments as professor of pharmacology and chemical biology and professor in the Clinical and Translational Science Institute. A translational breast cancer researcher, Dr. Davidson has published key findings on the role of hormones, particularly estrogen, on gene expression and cell growth in breast cancer. She has guided several important national clinical trials of potential new therapies, including chemoendocrine therapy for premenopausal breast cancer. Her research has been supported by a portfolio of funding from the National Institutes of Health (NIH), Department of Defense, Breast Cancer Research Foundation, and Susan Komen for the Cure. She has won several awards, including being elected to membership in the Association of American Physicians and the National Academy of Medicine. Dr. Davidson has coauthored over 300 articles in the top journals of her field and was named a Thomson Reuters Highly Cited Researcher in 2014 and 2015. A member of the scientific advisory board for many foundations and cancer centers. She was president of the American Society of Clinical Oncology from 2007-2008 and is serving as President of the American Association for Cancer Research in 2016-2017.